AIM
CVS icon

Aigen Investment Management’s CVS Health CVS Stock Holding History

Aigen Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,425
Closed -$351K – 585
2025
Q4 		$351K Sell
4,425
-1,591
-26% -$125K 0.08% 316
2025
Q3 		$454K Buy
+6,016
New +$412K 0.07% 420
2025
Q1 		– Sell
-12,413
Closed -$557K – 805
2024
Q4 		$557K Buy
+12,413
New +$696K 0.1% 304
2024
Q3 		– Sell
-25,134
Closed -$1.48M – 785
2024
Q2 		$1.48M Buy
25,134
+20,776
+477% +$1.3M 0.29% 87
2024
Q1 		$348K Sell
4,358
-1,013
-19% -$77.4K 0.08% 387
2023
Q4 		$424K Sell
5,371
-3,553
-40% -$253K 0.08% 382
2023
Q3 		$623K Sell
8,924
-85,575
-91% -$6.06M 0.12% 288
2023
Q2 		$6.53M Sell
94,499
-17,112
-15% -$1.22M 0.97% 7
2023
Q1 		$8.29M Buy
+111,611
New +$9.36M 1.14% 7
2022
Q4 		– Sell
-42,150
Closed -$4.02M – 581
2022
Q3 		$4.02M Buy
42,150
+22,022
+109% +$2.18M 0.58% 44
2022
Q2 		$1.86M Buy
20,128
+2,092
+12% +$204K 0.31% 92
2022
Q1 		$1.82M Buy
+18,036
New +$1.89M 0.31% 87
2020
Q1 		– Sell
-7
Closed -$1K – 1317
2019
Q4 		$1K Buy
+7
New +$492 ﹤0.01% 1064

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aigen Investment Management's CVS Position: Q1 2026 in Review

Aigen Investment Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 4,425 shares — an estimated $351K sold.

Aigen Investment Management first reported a position in CVS in Q4 2019 and held it in 13 quarters. The position peaked at $8.29M in Q1 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Aigen Investment Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 4,425 CVS Health shares in Q1 2026, an estimated $351K.
  • Aigen Investment Management first reported a position in CVS Health in Q4 2019 and held it in 13 quarters.
  • Aigen Investment Management's CVS Health position peaked at $8.29M in Q1 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.